$AXGN
Axogen, Inc. Stock $axgn

$axgn Overview Financials Valuation SEC Filings Company Website

2022 Q1 Form 10-Q Financial Statement

#000080592822000057 Filed on May 05, 2022

Income Statement

Concept	2022 Q1	2021 Q1
Revenue	$31.01M	$31.04M
YoY Change	-0.1%	27.93%
Cost Of Revenue	$5.546M	$5.172M
YoY Change	7.23%	7.39%
Gross Profit	$25.46M	$25.87M
YoY Change	-1.56%	33.02%
Gross Profit Margin	82.11%	83.34%
Selling, General & Admin	$30.51M	$26.34M
YoY Change	15.83%	12.84%
% of Gross Profit	119.81%	101.82%
Research & Development	$6.275M	$5.748M
YoY Change	9.17%	24.58%
% of Gross Profit	24.65%	22.22%
Depreciation & Amortization	$704.0K	$772.0K
YoY Change	-8.81%	151.47%
% of Gross Profit	2.77%	2.98%
Operating Expenses	$36.78M	$32.09M
YoY Change	14.64%	14.78%
Operating Profit	-$11.32M	-$6.220M
YoY Change	81.99%	-26.9%
Interest Expense	$354.0K	$444.0K
YoY Change	-20.27%	1332.26%
% of Operating Profit
Other Income/Expense, Net	-$155.0K	-$440.0K
YoY Change	-64.77%	-238.8%
Pretax Income	-$11.48M	-$6.660M
YoY Change	72.3%	-18.68%
Income Tax
% Of Pretax Income
Net Earnings	-$11.48M	-$6.660M
YoY Change	72.3%	-18.7%
Net Earnings / Revenue	-37.01%	-21.46%
Basic Earnings Per Share	-$0.27	-$0.16
Diluted Earnings Per Share	-$0.27	-$0.16
COMMON SHARES
Basic Shares Outstanding	41.80M shares	40.71M shares
Diluted Shares Outstanding	41.80M shares	40.71M shares

Balance Sheet

Concept	2022 Q1	2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$67.42M	$90.90M
YoY Change	-25.83%	9.52%
Cash & Equivalents	$14.56M	$39.84M
Short-Term Investments	$52.86M	$51.10M
Other Short-Term Assets	$9.067M	$11.00M
YoY Change	-17.57%	13.4%
Inventory	$17.40M	$13.39M
Prepaid Expenses
Receivables	$18.59M	$19.83M
Other Receivables	$0.00	$100.0K
Total Short-Term Assets	$112.5M	$135.1M
YoY Change	-16.77%	12.29%
LONG-TERM ASSETS
Property, Plant & Equipment	$82.36M	$44.40M
YoY Change	85.52%	121.28%
Goodwill
YoY Change
Intangibles	$3.190M	$2.328M
YoY Change	37.03%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$85.55M	$62.22M
YoY Change	37.49%	153.65%
TOTAL ASSETS
Total Short-Term Assets	$112.5M	$135.1M
Total Long-Term Assets	$85.55M	$62.22M
Total Assets	$198.0M	$197.4M
YoY Change	0.33%	36.23%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$20.87M	$9.157M
YoY Change	127.93%	27.46%
Accrued Expenses	$2.065M	$13.10M
YoY Change	-84.24%	6.5%
Deferred Revenue		$14.00K
YoY Change		0.0%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$8.000K	$0.00
YoY Change		-100.0%
Total Short-Term Liabilities	$22.95M	$22.27M
YoY Change	3.02%	14.29%
LONG-TERM LIABILITIES
Long-Term Debt	$45.04M	$32.14M
YoY Change	40.14%	2603.11%
Other Long-Term Liabilities	$26.19M	$2.000K
YoY Change	1309150.0%	-99.83%
Total Long-Term Liabilities	$45.04M	$32.14M
YoY Change	40.13%	2603.28%
TOTAL LIABILITIES
Total Short-Term Liabilities	$22.95M	$22.27M
Total Long-Term Liabilities	$45.04M	$32.14M
Total Liabilities	$94.17M	$77.67M
YoY Change	21.26%	275.39%
SHAREHOLDERS EQUITY
Retained Earnings	-$242.1M	-$210.3M
YoY Change	15.12%	11.83%
Common Stock	$346.0M	$330.0M
YoY Change	4.83%	5.69%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$103.9M	$119.7M
YoY Change
Total Liabilities & Shareholders Equity	$198.0M	$197.4M
YoY Change	0.33%	36.23%

Cashflow Statement

Concept	2022 Q1	2021 Q1
OPERATING ACTIVITIES
Net Income	-$11.48M	-$6.660M
YoY Change	72.3%	-18.7%
Depreciation, Depletion And Amortization	$704.0K	$772.0K
YoY Change	-8.81%	151.47%
Cash From Operating Activities	-$11.05M	-$10.82M
YoY Change	2.13%	34.38%
INVESTING ACTIVITIES
Capital Expenditures	$5.037M	$3.095M
YoY Change	62.75%	-38.36%
Acquisitions
YoY Change
Other Investing Activities	-$1.624M	$4.120M
YoY Change	-139.42%	-69.91%
Cash From Investing Activities	-$7.241M	$870.0K
YoY Change	-932.3%	-89.82%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$95.00K	$517.0K
YoY Change	-81.62%	-257.62%
NET CHANGE
Cash From Operating Activities	-$11.05M	-$10.82M
Cash From Investing Activities	-$7.241M	$870.0K
Cash From Financing Activities	$95.00K	$517.0K
Net Change In Cash	-$18.20M	-$9.433M
YoY Change	92.91%	-5648.82%
FREE CASH FLOW
Cash From Operating Activities	-$11.05M	-$10.82M
Capital Expenditures	$5.037M	$3.095M
Free Cash Flow	-$16.09M	-$13.92M
YoY Change	15.62%	6.44%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	22945000	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	24293000	USD
CY2022Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000805928
CY2022Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2022Q1	dei	Amendment Flag AmendmentFlag	false
CY2021Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://www.axogeninc.com/20200930/20220331#LeaseLiabilityCurrent
CY2022Q1	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://www.axogeninc.com/20200930/20220331#LeaseLiabilityCurrent
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://www.axogeninc.com/20200930/20220331#LeaseLiabilityNoncurrent
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://www.axogeninc.com/20200930/20220331#LeaseLiabilityNoncurrent
CY2021Q4	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://www.axogeninc.com/20200930/20220331#LeaseLiabilityCurrent
CY2022Q1	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://www.axogeninc.com/20200930/20220331#LeaseLiabilityCurrent
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://www.axogeninc.com/20200930/20220331#LeaseLiabilityNoncurrent
CY2022Q1	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://www.axogeninc.com/20200930/20220331#LeaseLiabilityNoncurrent
CY2022Q1	dei	Document Type DocumentType	10-Q
CY2022Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2022Q1	dei	Document Period End Date DocumentPeriodEndDate	2022-03-31
CY2022Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2022Q1	dei	Entity File Number EntityFileNumber	001-36046
CY2022Q1	dei	Entity Registrant Name EntityRegistrantName	Axogen, Inc.
CY2022Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MN
CY2022Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	13631 Progress Blvd., Suite 400
CY2022Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Alachua,
CY2022Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
CY2022Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	41-1301878
CY2022Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	32615
CY2022Q1	dei	City Area Code CityAreaCode	386
CY2022Q1	dei	Local Phone Number LocalPhoneNumber	462-6800
CY2022Q1	dei	Security12b Title Security12bTitle	Common Stock, $0.01 par value
CY2022Q1	dei	Trading Symbol TradingSymbol	AXGN
CY2022Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q1	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2022Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	41980607	shares
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14559000	USD
CY2022Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2022Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022Q1	dei	Entity Shell Company EntityShellCompany	false
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	32756000	USD
CY2022Q1	us-gaap	Restricted Cash RestrictedCash	6251000	USD
CY2021Q4	us-gaap	Restricted Cash RestrictedCash	6251000	USD
CY2022Q1	us-gaap	Short Term Investments ShortTermInvestments	52859000	USD
CY2021Q4	us-gaap	Short Term Investments ShortTermInvestments	51330000	USD
CY2022Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	366000	USD
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	276000	USD
CY2022Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	18590000	USD
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	18158000	USD
CY2022Q1	us-gaap	Inventory Net InventoryNet	17400000	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	16693000	USD
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	420000	USD
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	417000	USD
CY2022Q1	axgn	Lease Liability Noncurrent LeaseLiabilityNoncurrent	20878000	USD
CY2022Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2816000	USD
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1861000	USD
CY2022Q1	us-gaap	Assets Current AssetsCurrent	112475000	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	127049000	USD
CY2022Q1	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	66954000	USD
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	62923000	USD
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	15406000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	15193000	USD
CY2022Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3190000	USD
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2859000	USD
CY2022Q1	us-gaap	Assets Assets	198025000	USD
CY2021Q4	us-gaap	Assets Assets	208024000	USD
CY2022Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	20872000	USD
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	22459000	USD
CY2022Q1	axgn	Lease Liability Current LeaseLiabilityCurrent	2073000	USD
CY2021Q4	axgn	Lease Liability Current LeaseLiabilityCurrent	1834000	USD
CY2022Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	45041000	USD
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	44821000	USD
CY2021Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	5562000	USD
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	41972987	shares
CY2022Q1	us-gaap	Liabilities Liabilities	94174000	USD
CY2021Q4	us-gaap	Liabilities Liabilities	95474000	USD
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	41736950	shares
CY2021Q4	axgn	Lease Liability Noncurrent LeaseLiabilityNoncurrent	20798000	USD
CY2022Q1	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	5310000	USD
CY2022Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	41972987	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	41736950	shares
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-230632000	USD
CY2022Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	345538000	USD
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	342765000	USD
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-242107000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	103851000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	112550000	USD
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	198025000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	208024000	USD
CY2022Q1	us-gaap	Revenues Revenues	31007000	USD
CY2021Q1	us-gaap	Revenues Revenues	31037000	USD
CY2022Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	5546000	USD
CY2021Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	5172000	USD
CY2022Q1	us-gaap	Gross Profit GrossProfit	25461000	USD
CY2021Q1	us-gaap	Gross Profit GrossProfit	25865000	USD
CY2022Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	20888000	USD
CY2021Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	17973000	USD
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6275000	USD
CY2021Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5748000	USD
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9618000	USD
CY2022Q1	us-gaap	Interest Expense InterestExpense	354000	USD
CY2021Q1	us-gaap	Interest Expense InterestExpense	444000	USD
CY2021Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-440000	USD
CY2022Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	252000	USD
CY2021Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8364000	USD
CY2022Q1	us-gaap	Costs And Expenses CostsAndExpenses	36781000	USD
CY2021Q1	us-gaap	Costs And Expenses CostsAndExpenses	32085000	USD
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-11320000	USD
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-6220000	USD
CY2022Q1	us-gaap	Investment Income Net InvestmentIncomeNet	-46000	USD
CY2021Q1	us-gaap	Investment Income Net InvestmentIncomeNet	34000	USD
CY2021Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-22000	USD
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-7000	USD
CY2021Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-8000	USD
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-155000	USD
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	41804330	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	40705840	shares
CY2021Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	772000	USD
CY2022Q1	axgn	Right Of Use Asset Amortization RightOfUseAssetAmortization	427000	USD
CY2021Q1	axgn	Right Of Use Asset Amortization RightOfUseAssetAmortization	500000	USD
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	69000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-11475000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-6660000	USD
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.27
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.27
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.16
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.16
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-11475000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-6660000	USD
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	704000	USD
CY2021Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	47000	USD
CY2022Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	220000	USD
CY2021Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	112000	USD
CY2022Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	267000	USD
CY2021Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-26000	USD
CY2022Q1	us-gaap	Inventory Write Down InventoryWriteDown	459000	USD
CY2021Q1	us-gaap	Inventory Write Down InventoryWriteDown	783000	USD
CY2022Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	252000	USD
CY2021Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-22000	USD
CY2022Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-96000	USD
CY2021Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-15000	USD
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2678000	USD
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2694000	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	624000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2181000	USD
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1166000	USD
CY2021Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1642000	USD
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1030000	USD
CY2021Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	313000	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1104000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-5061000	USD
CY2022Q1	axgn	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	320000	USD
CY2021Q1	axgn	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-119000	USD
CY2022Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	0	USD
CY2021Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-1000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-11051000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-10820000	USD
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5037000	USD
CY2021Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3095000	USD
CY2022Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	6024000	USD
CY2021Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	15279000	USD
CY2022Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	4400000	USD
CY2021Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	19400000	USD
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	0	USD
CY2022Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	580000	USD
CY2021Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	156000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-7241000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	870000	USD
CY2022Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	2000	USD
CY2021Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	4000	USD
CY2022Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	97000	USD
CY2021Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	521000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	95000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	517000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-18197000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-9433000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	39007000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	55609000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	20810000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	46176000	USD
CY2021Q1	us-gaap	Interest Paid Net InterestPaidNet	312000	USD
CY2022Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1119000	USD
CY2021Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	4836000	USD
CY2022Q1	axgn	Noncash Right Of Use Assets And Operating Lease Liability NoncashRightOfUseAssetsAndOperatingLeaseLiability	641000	USD
CY2021Q1	axgn	Noncash Right Of Use Assets And Operating Lease Liability NoncashRightOfUseAssetsAndOperatingLeaseLiability	321000	USD
CY2022Q1	us-gaap	Noncash Or Part Noncash Acquisition Intangible Assets Acquired1 NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1	239000	USD
CY2021Q1	us-gaap	Noncash Or Part Noncash Acquisition Intangible Assets Acquired1 NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1	166000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	112550000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-11475000	USD
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2678000	USD
CY2022Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	0	USD
CY2022Q1	axgn	Stock Issued During Period Value Stock Options Exercised And Employee Stock Purchase Plan StockIssuedDuringPeriodValueStockOptionsExercisedAndEmployeeStockPurchasePlan	98000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	103851000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	123149000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-6660000	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2694000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	0	USD
CY2021Q1	axgn	Stock Issued During Period Value Stock Options Exercised And Employee Stock Purchase Plan StockIssuedDuringPeriodValueStockOptionsExercisedAndEmployeeStockPurchasePlan	521000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	119704000	USD
CY2022Q1	us-gaap	Basis Of Accounting BasisOfAccounting	Basis of Presentation<div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless the context otherwise requires, all references in these Notes to “Axogen,” the “Company," “we,” “us” and “our” refer to Axogen, Inc. and its wholly owned subsidiaries Axogen Corporation (“AC”), Axogen Processing Corporation, and Axogen Europe GmbH.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed consolidated financial statements include the accounts of the Company as of March 31, 2022, and December 31, 2021 and for the three months ended March 31, 2022 and 2021. The Company’s condensed consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X, and therefore, do not include all information and footnotes necessary for a fair presentation of consolidated financial position, results of operations, and cash flows in conformity with accounting principles generally accepted in the United States of America (“US GAAP”) and should be read in conjunction with the audited financial statements of the Company for the year ended December 31, 2021, which are included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The interim condensed consolidated financial statements are unaudited and in the opinion of management, reflect all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of results for the periods presented. Results for interim periods are not necessarily indicative of results for the full year. All intercompany accounts and transactions have been eliminated in consolidation. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of operations for the three months ended March 31, 2022, are not necessarily indicative of the results to be expected for the full year due primarily to the impact of the continued uncertainty of general economic conditions that may impact our markets for the remainder of fiscal year 2022. Specifically, there can be no assurances that resurgences of COVID-19 will not affect future results.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the reporting results of operations.</span></div>
CY2022Q1	us-gaap	Cash Uninsured Amount CashUninsuredAmount	14059000	USD
CY2022Q1	us-gaap	Restricted Cash RestrictedCash	6251000	USD
CY2021Q4	us-gaap	Restricted Cash RestrictedCash	6251000	USD
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14559000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	32756000	USD
CY2022Q1	us-gaap	Restricted Cash RestrictedCash	6251000	USD
CY2021Q4	us-gaap	Restricted Cash RestrictedCash	6251000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	20810000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	39007000	USD
CY2022Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	11856000	USD
CY2021Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	11011000	USD
CY2022Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	851000	USD
CY2021Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	813000	USD
CY2022Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	4693000	USD
CY2021Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	4869000	USD
CY2022Q1	us-gaap	Inventory Net InventoryNet	17400000	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	16693000	USD
CY2022Q1	us-gaap	Inventory Write Down InventoryWriteDown	459000	USD
CY2021Q1	us-gaap	Inventory Write Down InventoryWriteDown	783000	USD
CY2022Q1	us-gaap	Finance Lease Right Of Use Asset Before Accumulated Amortization FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization	110000	USD
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset Before Accumulated Amortization FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization	110000	USD
CY2022Q1	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	75272000	USD
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	70537000	USD
CY2022Q1	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	8318000	USD
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	7614000	USD
CY2022Q1	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	66954000	USD
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	62923000	USD
CY2022Q1	us-gaap	Depreciation Depreciation	704000	USD
CY2021Q1	us-gaap	Depreciation Depreciation	772000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	3962000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1156000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2806000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	3570000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1086000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2484000	USD
CY2022Q1	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	4346000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1156000	USD
CY2022Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3190000	USD
CY2021Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	3945000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1086000	USD
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2859000	USD
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	69000	USD
CY2021Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	47000	USD
CY2022Q1	us-gaap	Lease Cost LeaseCost	1408000	USD
CY2021Q1	us-gaap	Lease Cost LeaseCost	1225000	USD
CY2022Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1026
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	15406000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	15193000	USD
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2065000	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1825000	USD
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	20875000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	20794000	USD
CY2022Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	36000	USD
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	42000	USD
CY2022Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	8000	USD
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	9000	USD
CY2022Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	3000	USD
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	4000	USD
CY2022Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P11Y2M12D
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P12Y1M6D
CY2022Q1	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P1Y4M24D
CY2021Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P2Y2M12D
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1032
CY2022Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0709
CY2021Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0723
CY2022Q1	axgn	Lessee Operating And Financing Lease Liability To Be Paid Remainder Of Fiscal Year LesseeOperatingAndFinancingLeaseLiabilityToBePaidRemainderOfFiscalYear	3213000	USD
CY2022Q1	axgn	Lessee Operating And Financing Lease Liability To Be Paid Year One LesseeOperatingAndFinancingLeaseLiabilityToBePaidYearOne	3415000	USD
CY2022Q1	axgn	Lessee Operating And Financing Lease Liability To Be Paid Year Two LesseeOperatingAndFinancingLeaseLiabilityToBePaidYearTwo	3186000	USD
CY2022Q1	axgn	Lessee Operating And Financing Lease Liability To Be Paid Year Three LesseeOperatingAndFinancingLeaseLiabilityToBePaidYearThree	3268000	USD
CY2022Q1	axgn	Lessee Operating And Financing Lease Liability To Be Paid Year Four LesseeOperatingAndFinancingLeaseLiabilityToBePaidYearFour	3276000	USD
CY2022Q1	axgn	Lessee Operating And Financing Lease Liability To Be Paid After Year Four LesseeOperatingAndFinancingLeaseLiabilityToBePaidAfterYearFour	24056000	USD
CY2022Q1	axgn	Lessee Operating And Financing Lease Liability To Be Paid LesseeOperatingAndFinancingLeaseLiabilityToBePaid	40414000	USD
CY2022Q1	axgn	Lessee Operating And Financing Lease Liability Undiscounted Excess Amount LesseeOperatingAndFinancingLeaseLiabilityUndiscountedExcessAmount	17463000	USD
CY2022Q1	axgn	Operating And Financing Lease Liability OperatingAndFinancingLeaseLiability	22951000	USD
CY2022Q1	axgn	Operating And Financing Lease Liability Current OperatingAndFinancingLeaseLiabilityCurrent	2073000	USD
CY2022Q1	axgn	Operating And Financing Lease Liability Noncurrent OperatingAndFinancingLeaseLiabilityNoncurrent	20878000	USD
CY2022Q1	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	4959000	USD
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	5179000	USD
CY2022Q1	us-gaap	Long Term Debt LongTermDebt	45041000	USD
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	44821000	USD
CY2022Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	219000	USD
CY2021Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	112000	USD
CY2022Q1	us-gaap	Restricted Cash RestrictedCash	6251000	USD
CY2021Q4	us-gaap	Restricted Cash RestrictedCash	6251000	USD
CY2022Q1	axgn	Share Base Payment Arrangement Number Of Plans ShareBasePaymentArrangementNumberOfPlans	2	plan
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2678000	USD
CY2021Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2694000	USD
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.6074
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0215
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2022Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	11152000	USD
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y1M13D
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-11475000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-6660000	USD
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	41804330	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	40705840	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	41804330	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	40705840	shares
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.27
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.27
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.16
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.16
CY2019Q1	axgn	Threshold Period For Not Filing Response To Complaint ThresholdPeriodForNotFilingResponseToComplaint	P30D

Files In Submission

Name	View Source	Status
0000805928-22-000057-index-headers.html	Edgar Link	pending
0000805928-22-000057-index.html	Edgar Link	pending
0000805928-22-000057.txt	Edgar Link	pending
0000805928-22-000057-xbrl.zip	Edgar Link	pending
axgn-20220331.htm	Edgar Link	pending
axgn-20220331.xsd	Edgar Link	pending
axgn-20220331_cal.xml	Edgar Link	unprocessable
axgn-20220331_def.xml	Edgar Link	unprocessable
axgn-20220331_htm.xml	Edgar Link	completed
axgn-20220331_lab.xml	Edgar Link	unprocessable
axgn-20220331_pre.xml	Edgar Link	unprocessable
axgnfy22q1ex31111.htm	Edgar Link	pending
axgnfy22q1ex3121.htm	Edgar Link	pending
axgnfy22q1ex321.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AXGN
Axogen, Inc. Stock $axgn

2022 Q1 Form 10-Q Financial Statement

#000080592822000057 Filed on May 05, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AXGN Axogen, Inc. Stock $axgn

2022 Q1 Form 10-Q Financial Statement

#000080592822000057 Filed on May 05, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AXGN
Axogen, Inc. Stock $axgn